Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:

NCT ID: NCT00000553 Completed - Clinical trials for Cardiovascular Diseases

HDL-Atherosclerosis Treatment Study (HATS)

Start date: September 1994
Phase: Phase 3
Study type: Interventional

To measure the effects of lipid-lowering drugs and/or antioxidant vitamins on progression or regression of coronary heart disease as measured by quantitative angiography in patients with low high density lipoprotein (HDL) cholesterol.

NCT ID: NCT00000552 Completed - Clinical trials for Cardiovascular Diseases

Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Start date: September 1994
Phase: Phase 3
Study type: Interventional

To test if early revascularization, primarily with angioplasty (PTCA) or bypass surgery (CABG), reduced all-cause in-hospital mortality from cardiogenic shock compared to conventional treatment, including thrombolysis.

NCT ID: NCT00000551 Completed - Clinical trials for Cardiovascular Diseases

Activity Counseling Trial (ACT)

Start date: September 1994
Phase: Phase 3
Study type: Interventional

To develop and evaluate the effectiveness of various intervention approaches, delivered in primary health-care settings, in increasing and maintaining habitual physical activity and cardiorespiratory fitness among sedentary men and women patients.

NCT ID: NCT00000550 Completed - Clinical trials for Cardiovascular Diseases

Rapid Early Action for Coronary Treatment (REACT)

Start date: August 1994
Phase: Phase 3
Study type: Interventional

To evaluate the impact of community educational interventions on patient delay time from onset of symptoms and signs of an acute myocardial infarction (AMI) to arrival at a hospital Emergency Department (ED). Also, to study the impact of community educational interventions on use of Emergency Medical Services (EMS) and EDs, on thrombolytic therapy, and on AMI case fatality.

NCT ID: NCT00000549 Completed - Clinical trials for Cardiovascular Diseases

Estrogen Replacement and Atherosclerosis (ERA) in Older Women

Start date: August 1994
Phase: Phase 3
Study type: Interventional

To determine if estrogen replacement therapy, with or without low dose progesterone, slows progression or induces regression of coronary atherosclerosis in postmenopausal women.

NCT ID: NCT00000547 Completed - Heart Failure Clinical Trials

Enalapril After Anthracycline Cardiotoxicity

Start date: April 1994
Phase: Phase 3
Study type: Interventional

To determine if the chronic administration of enalapril, an inhibitor of angiotensin converting enzyme (ACE), reduces progression of cardiac dysfunction in pediatric oncology patients who have received anthracyclines, and who are not currently on digoxin, diuretics, or vasodilators for heart failure.

NCT ID: NCT00000546 Completed - Hypertension Clinical Trials

Stress Reduction and Atherosclerotic CVD in Blacks

Start date: March 1994
Phase: Phase 3
Study type: Interventional

To evaluate the effectiveness of stress reduction with Transcendental Meditation (TM) on left ventricular hypertrophy, left ventricular function, blood pressure, psychosocial stress and quality of life, and cardiovascular disease risk factors.

NCT ID: NCT00000545 Completed - Obesity Clinical Trials

PATHWAYS--FULL SCALE STUDY

Start date: September 1993
Phase: Phase 2
Study type: Interventional

To implement a culturally appropriate school-based, multicenter, randomized trial that promotes healthful eating behaviors and increases physical activity to prevent obesity in pre-adolescent upper elementary American Indian students.

NCT ID: NCT00000544 Completed - Hypertension Clinical Trials

Dietary Approaches to Stop Hypertension (DASH)

Start date: August 1993
Phase: Phase 3
Study type: Interventional

To test the effectiveness of dietary patterns in lowering blood pressure.

NCT ID: NCT00000543 Completed - Hypertension Clinical Trials

Oral Calcium in Pregnant Women With Hypertension

Start date: August 1993
Phase: Phase 2
Study type: Interventional

To determine of providing calcium supplementation to women with pre-existing hypertension reduces the level of blood pressure, requirement for antihypertensive drugs, and incidence of pre-eclampsia.